Multipurpose approach to the treatment of chronic heart failure: implantation of system subcutaneous cardioverter-defibrillator and cardiac contractility modulation device. A case report
V. A. Amanatova,
T. M. Uskach,
I. R. Grishin,
A. V. Vereshchagina,
A. A. Safiullina,
O. V. Sapelnikov,
S. N. Tereshchenko https://doi.org/10.35336/VA-1365
EDN: JJFLPV
Abstract
A clinical case of patient with implanted system subcutaneous cardioverter-defibrillator and cardiac contractility modulation device is described. No violations were identified in the joint operation of the devices.
About the Authors
V. A. Amanatova
FSBI “NMRC of Cardiology named after acad. E.I.Chazov” of the MH RF
Russian Federation
Russian Federation
Amanatova Valeria
Moscow, 15A Academician Chazov str.
T. M. Uskach
FSBI “NMRC of Cardiology named after acad. E.I.Chazov” of the MH RF; FSBEI APE “Russian Medical Academy of Continuous Professional Education” of the MH RF
Russian Federation
Russian Federation
Moscow, 15A Academician Chazov str.;
Moscow, 2/1 Barrikadnaya str., buil. 1
I. R. Grishin
FSBI “NMRC of Cardiology named after acad. E.I.Chazov” of the MH RF
Russian Federation
Russian Federation
Moscow, 15A Academician Chazov str.
A. V. Vereshchagina
FSBI “NMRC of Cardiology named after acad. E.I.Chazov” of the MH RF
Russian Federation
Russian Federation
Moscow, 15A Academician Chazov str.
A. A. Safiullina
FSBI “NMRC of Cardiology named after acad. E.I.Chazov” of the MH RF
Russian Federation
Russian Federation
Moscow, 15A Academician Chazov str.
O. V. Sapelnikov
FSBI “NMRC of Cardiology named after acad. E.I.Chazov” of the MH RF
Russian Federation
Russian Federation
Moscow, 15A Academician Chazov str.
S. N. Tereshchenko
FSBI “NMRC of Cardiology named after acad. E.I.Chazov” of the MH RF; FSBEI APE “Russian Medical Academy of Continuous Professional Education” of the MH RF
Russian Federation
Russian Federation
Moscow, 15A Academician Chazov str.;
Moscow, 2/1 Barrikadnaya str., buil. 1
References
1. Santangeli P, Rame JE, Birati EY, Marchlinski FE. Management of Ventricular Arrhythmias in Patients With Advanced Heart Failure. J Am Coll Cardiol. 2017;69(14): 1842-1860. https://doi.org/10.1016/j.jacc.2017.01.047.
2. Wong CX, Brown A, Lau DH, et al. Epidemiology of Sudden Cardiac Death: Global and Regional Perspectives. Heart Lung Circ. 2019;28(1): 6-14. https://doi.org/10.1016/j.hlc.2018.08.026.
3. 2020 Clinical practice guidelines for chronic heart failure. Russian Journal of Cardiology. 2020;25(11): 4083. (In Russ.). https://doi.org/10.15829/1560-4071-2020-4083.
4. Aivazyan SA, Sapelnikov OV, Grishin IR, Sorokin IN. Risk stratification scales for extraction of electrodes in cardiac implantable electronic devices and prospects for their practical application: a review of the literature. Journal of arrhythmology. 2022;29(2): 50-57 (In Russ.). https://doi.org/10.35336/VA-2022-2-05.
5. Vereshchagina AV, Uskach TM., Sapelnikov OV, et al. Safety and Tolerability of Implanted Subcutaneous Cardioverter-defibrillator Systems. Rational Pharmacotherapy in Cardiology. 2022;18(4): 427-432. (In Russ.). https://doi.org/10.20996/1819-6446-2022-08-05.
6. Vereshchagina AV, Uskach TM, Sapelnikov OV, et al. Preimplantation screening of patients-candidates for implantation of a subcutaneous cardioverter-defibrillator: predictors of the out-comes. Russian Cardiology Bulletin. 2021;16(4): 58-65. (In Russ.). https://doi.org/10.17116/Cardiobulletin20211604158.
7. Prokopenko AV, Ivanitskiy EA. Subcutaneous cardioverter-defibrillator, patient selection, implantation, postoperative management in the Krasnoyarsk. Russian Journal of Cardiology. 2022;27(8): 104-108. https://doi.org/10.15829/1560-4071-2022-5116.
8. Prokopenko AV, Ivanitskiy EA. Experience of the using of subcutaneous cardioverter-defibrillators in the world practice: review. Journal of Arrhythmology. 2022;29(4): 42-46 (In Russ.). https://doi.org/10.35336/VA-2022-4-06.
9. Lund LH, Jurga J, Edner M, et al. Prevalence, correlates, and prognostic significance of QRS prolongation in heart failure with reduced and preserved ejection fraction. Eur Heart J. 2013;34(7): 529-39. https://doi.org/10.1093/eurheartj/ehs305.
10. Davtyan KV, Mironova NA, Chugunov IA, et al. Cardiac contractility modulation therapy in patients with implanted cardiac resynchronization therapy: results of the 2 year follow-up. Journal of Arrhythmology. 2023;30(3): 16-22 (In Russ.). https://doi.org/10.35336/VA-1145.
11. Uskach TM, Sapelnikov OV, Safiullina AA, et al. Implantation of a cardiac contractility modulator in chronic heart failure and atrial fibrillation: results of a 6-month follow-up of one hundred patients. Russian Journal of Transplantology and Artificial Organs. 2021;23(1): 30-37 (In Russ.). https://doi.org/10.15825/1995-1191-2021-1-30-37.
12. Lyasnikova EA, Sukhareva KS, Vander MA, et al. Molecular effects of cardiac contractility modulation in patients with heart failure of ischemic aetiology uncovered by transcriptome analysis. Frontiers in Cardiovascular Medicine. 2024;11: 1321005. https://doi.org/10.3389/fcvm.2024.1321005.
13. Yao J, Gao J, Yan J-F, Fang S. Cardiac contractilitymodulation and subcutaneous defibrillator (S-ICD): First experience with simultaneous implantation. Pacing Clin Electrophysiol. 2023;1-4. https://doi.org/10.1111/pace.14695.
14. Röger S, Rudic B, Akin I, et al. Long-term results of combined cardiac contractility modulation and subcutaneous defibrillator therapy in patients with heart failure and reduced ejection fraction. Clin Cardiol. 2018;41(4): 518-524. https://doi.org/10.1002/clc.22919.
15. User Manual EMBLEM S-ICD, EMBLEM MRI S-ICD. Subcutaneous implantable cardioverter defibrillator. Available from: https://www.bostonscientific.com/content/dam/elabeling/crm/92346913-027_EMBLEM_S-ICD_UM_en_S.pdf.
Review
For citations:
Amanatova V.A., Uskach T.M., Grishin I.R., Vereshchagina A.V., Safiullina A.A., Sapelnikov O.V., Tereshchenko S.N. Multipurpose approach to the treatment of chronic heart failure: implantation of system subcutaneous cardioverter-defibrillator and cardiac contractility modulation device. A case report. Journal of Arrhythmology. 2024;31(4):е7. https://doi.org/10.35336/VA-1365. EDN: JJFLPV
Views:
979
Email this article 